Recommendation of colorectal cancer testing among primary care patients younger than 50 with elevated risk
- PMID: 28625419
- PMCID: PMC5557096
- DOI: 10.1016/j.ypmed.2017.06.014
Recommendation of colorectal cancer testing among primary care patients younger than 50 with elevated risk
Abstract
In the era of precision medicine, efforts are needed to identify and tailor screening recommendations among elevated-risk patients. Individuals younger than 50years are an important target population, as they comprise 15% of colorectal (CRC) cases and often present with more advanced disease than their 50+ counterparts. In this large study, 2470 patients ages 25-49 used a tablet-based program that assessed risks, matched risks with screening guidelines, and generated tailored printed guideline-concordant recommendations for patients and their providers. The tablet-based program identified 121 (4.9%) patients with risk factors warranting screening before age 50. Likelihood of risk warranting screening was greater for ages 40-49 than <40years (OR: 2.38), females than males (OR: 1.82), and African Americans (OR: 1.69) and non-Hispanic Whites (OR: 2.89) compared to Hispanics. Most common risk factors were family history of polyps (23.1%), personal history of inflammatory bowel disease (19.8%), and combined family history of CRC+polyps (18.2%). Receipt of guideline-concordant screening within 6months of identification was low, including only 5.3% of those who needed colonoscopy and 13.3% for whom colonoscopy or FIT was recommended. Although elevated-risk patients younger than 50years can be readily identified, more than notification is necessary to facilitate screening participation.
Keywords: Cancer screening; Decision support; Tailored interventions.
Copyright © 2017 Elsevier Inc. All rights reserved.
Conflict of interest statement
No conflicts of interest are declared by the authors.
References
-
- U.S. Preventive Services Task Force. Screening for Colorecal Cancer. Recommendation Statement. JAMA. 2016;315(23):2564–2575. http://dx.doi.org/10.1001/jama.2016.5989. - DOI - PubMed
-
- Winawer S, Fletcher R, Rex D, et al. Colorectal cancer screening and surveillance: clinical guidelines and rationale-Update based on new evidence. Gastroenterology. 2003;124(2):544–560. http://dx.doi.org/10.1053/gast.2003.50044. - DOI - PubMed
-
- Levin B, Lieberman DA, McFarland B, et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology. 2008;134(5):1570–1595. http://dx.doi.org/10.1053/j.gastro.2008.02.002. - DOI - PubMed
-
- Abdelsattar ZM, Wong SL, Regenbogen SE, Jomaa DM, Hardiman KM, Hendren S. Colorectal cancer outcomes and treatment patterns in patients too young for average-risk screening. Cancer. 2016;122(6):929–934. http://dx.doi.org/10.1002/cncr.29716. - DOI - PMC - PubMed
-
- Bailey CE, Hu CY, You YN, et al. Increasing disparities in the age-related incidences of colon and rectal cancers in the United States, 1975–2010. JAMA Surg. 2015;150(1):17–22. http://dx.doi.org/10.1001/jamasurg.2014.1756. - DOI - PMC - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
